1933 Industries and Tony Hawk Roll Out New CBD Sports Relief Balm

Iconic professional skateboarder Tony Hawk, through his company House of Hawk LLC and under his Birdhouse Skateboards brand, has partnered with 1933 Industries to produce Birdhouse CBD Calm by Canna Hemp X. The CBD balm is designed to help athletes recover from injury and training. While the partnership was announced in the spring, sales began this week. 

“We’re excited to be a part of this new movement that is becoming more recognized as a healthy alternative to recovering from the aches and pains that we regularly incur in the action sports world. And we couldn’t be happier to join forces with Canna Hemp, an established and trusted partner with an expertise in this market,” Hawk said in a release.


On his Instagram last week, Hawk said he used the cream himself after working on a new skate trick. “It was a brutal battle but I’ve already recovered thanks to @cannahempx,” he wrote.

1933 Industries Chief Executive Officer Chris Rebentisch is hoping the partnership with Hawk can help take his company to new heights.

“It’s truly an honor to be working with Tony Hawk’s Birdhouse Skateboards brand and their incredible organization,” Rebentisch said. “The opportunity of offering our sports recovery products under a partnership with Hawk’s brand Birdhouse adds credence to our brand. Tony is an internationally recognized action sports figure and responsible for fueling the growth of skateboarding as a professional sport.”

For Rebentisch, the partnership with Hawk must be an exciting new chapter for Canna Hemp X, though the company has enjoyed some success already. Hemp X offers a fairly large product line that includes CBD infused elixirs, vapes, capsules, lotions, lip balms, and creams. Despite the varied product line, Rebentisch thinks there could be many more uses on the horizon for CBD.

“We are just starting to scratch the surface of the many applications associated with the cannabis plant and we are pleased to be part of a national conversation about its potential,” Rebentisch said. “The anecdotal benefits keep mounting and we believe that this market is under served.”